Recent Events & Catalysts
Qiagen N.V. (QGEN) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
QIAGEN Says FDA Clears QIAstat-Dx BCID GPF Plus AMR Panel For Bloodstream Infections
Benzinga · 1d ago
Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45
Benzinga · 1d ago
Qiagen Q2 Earnings Call Highlights
Yahoo · 2d ago
Barclays Maintains Equal-Weight on Qiagen, Raises Price Target to $40
Benzinga · 4d ago
JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $50
Benzinga · 4d ago
Conference Call:
Qiagen Q3 Adj EPS expected to be more than $0.62 vs $0.64 Est; Sees Q3 Sales $538.330M-$543.660M vs $552.590M Est
Benzinga · 5d ago
Qiagen N.V. (QGEN) Q2 2026 Earnings Call Transcript
SeekingAlpha · 5d ago
Qiagen N.V. Q2 2026 Earnings Call Summary
Yahoo · 5d ago
SEC Filings (90 days)
No 8-K filings in the last 90 days.
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.